MRK Stock: Merck & Co., Inc. Stock Price, Analysis & Insights
Get live MRK stock price $115.87, comprehensive Merck & Co., Inc. stock analysis, charts, news, and expert forecast. Real-time MRK stock data and investment insights.
Loading chart data...
Merck & Co., Inc. (MRK) Overview
Merck & Co., Inc. (MRK) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, MRK trades at $115.87 with a market capitalization of 286.18B . Over the past 52 weeks, MRK has traded between $75.40 and $125.14 , with the current price positioned at approximately 81% of this range . The stock curren...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 286.18B
- Current price: $115.87
- 52-week range: $75.40 - $125.14
- P/E ratio: 32.64
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, im...
Company Information
- CEO
- Robert Davis
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 73000
Contact Information
- Website
- https://www.merck.com
- Address
- 126 East Lincoln Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 286.2 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 32.6)
✓ Lower volatility stock (Beta: 0.20) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Merck & Co., Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Merck & Co., Inc.
- ⚠Investors should consider how Merck & Co., Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 32.6) requires strong growth to justify
Market Cap
286.18B
P/E Ratio (TTM)
32.64
Beta
0.20
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Healthcare Stocks
Compare MRK with:
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.